Anthera Pharmaceuticals 

We are focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs.

Find out more about what we are doing for patients with Cystic Fibrosis and IgA Nephropathy:

Cystic Fibrosis
IgA Nephropathy

Anthera Pharmaceuticals Surpasses 50% Milestone for Screening of Patients in the RESULT Phase 3 Clinical Study of Sollpura in Cystic Fibrosis. Read more

Anthera Pharmaceuticals to Present at Rodman & Renshaw 18th Annual Global Investment Conference. Read more

Print Friendly